Genovis AB (publ.) Balance Sheet Health
Financial Health criteria checks 6/6
Genovis AB (publ.) has a total shareholder equity of SEK190.8M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK288.9M and SEK98.0M respectively. Genovis AB (publ.)'s EBIT is SEK54.0M making its interest coverage ratio -86.3. It has cash and short-term investments of SEK123.3M.
Key information
0%
Debt to equity ratio
kr0
Debt
| Interest coverage ratio | -86.3x |
| Cash | kr123.26m |
| Equity | kr190.81m |
| Total liabilities | kr98.05m |
| Total assets | kr288.86m |
Recent financial health updates
No updates
Recent updates
Is Now The Time To Look At Buying Genovis AB (publ.) (STO:GENO)?
Mar 18
What You Can Learn From Genovis AB (publ.)'s (STO:GENO) P/EAfter Its 25% Share Price Crash
Feb 28We Think That There Are Issues Underlying Genovis AB (publ.)'s (STO:GENO) Earnings
Feb 22These Analysts Just Made A Huge Downgrade To Their Genovis AB (publ.) (STO:GENO) EPS Forecasts
Feb 20Genovis AB (publ.) (STO:GENO) Analysts Are More Bearish Than They Used To Be
Feb 04Here's Why Genovis AB (publ.) (STO:GENO) Has Caught The Eye Of Investors
Oct 06Are Genovis AB (publ.) (STO:GENO) Investors Paying Above The Intrinsic Value?
Jun 22What Does Genovis AB (publ.)'s (STO:GENO) Share Price Indicate?
May 13Do Genovis AB (publ.)'s (STO:GENO) Earnings Warrant Your Attention?
Dec 22Should You Think About Buying Genovis AB (publ.) (STO:GENO) Now?
Nov 14If EPS Growth Is Important To You, Genovis AB (publ.) (STO:GENO) Presents An Opportunity
Jul 08Is There An Opportunity With Genovis AB (publ.)'s (STO:GENO) 43% Undervaluation?
Jun 01Genovis AB (publ.)'s (STO:GENO) Popularity With Investors Under Threat As Stock Sinks 27%
May 10One Analyst Just Shaved Their Genovis AB (publ.) (STO:GENO) Forecasts Dramatically
Feb 10Is Now The Time To Put Genovis AB (publ.) (STO:GENO) On Your Watchlist?
Aug 09What Is Genovis AB (publ.)'s (STO:GENO) Share Price Doing?
Mar 27How Does Genovis AB (publ.)'s (STO:GENO) CEO Pay Compare With Company Performance?
Dec 30Is Now An Opportune Moment To Examine Genovis AB (publ.) (STO:GENO)?
Nov 23
Financial Position Analysis
Short Term Liabilities: GENO's short term assets (SEK159.0M) exceed its short term liabilities (SEK21.2M).
Long Term Liabilities: GENO's short term assets (SEK159.0M) exceed its long term liabilities (SEK76.8M).
Debt to Equity History and Analysis
Debt Level: GENO is debt free.
Reducing Debt: GENO had no debt 5 years ago.
Debt Coverage: GENO has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: GENO has no debt, therefore coverage of interest payments is not a concern.